| Literature DB >> 36234779 |
Hadeer Darwish1, Sarah Alharthi2, Radwa A Mehanna3,4, Samar S Ibrahim4, Mustafa A Fawzy5, Saqer S Alotaibi1, Sarah M Albogami1, Bander Albogami5, Sedky H A Hassan6, Ahmed Noureldeen5.
Abstract
Chemotherapy is an aggressive form of chemical drug therapy aiming to destroy cancer cells. Adjuvant therapy may reduce hazards of chemotherapy and help in destroying these cells when obtained from natural products, such as medical plants. In this study, the potential therapeutic effect of Rosa damascena callus crude extract produced in vitamin-enhanced media is investigated on colorectal cancer cell line Caco-2. Two elicitors, i.e., L-ascorbic acid and citric acid at a concentration of 0.5 g/L were added to the callus induction medium. Callus extraction and the GC-MS analysis of methanolic crude extracts were also determined. Cytotoxicity, clonogenicity, proliferation and migration of Caco-2 colorectal cancer cells were investigated using MTT cytotoxicity, colony-forming, Ki-67 flow cytometry proliferation and Migration Scratch assays, respectively. Our results indicated that L-ascorbic acid treatment enhanced callus growth parameters and improved secondary metabolite contents. It showed the least IC50 value of 137 ug/mL compared to 237 ug/mL and 180 ug/mL in the citric acid-treated and control group. We can conclude that R. damascena callus elicited by L-ascorbic acid improved growth and secondary metabolite contents as well as having an efficient antiproliferative, anti-clonogenic and anti-migratory effect on Caco-2 cancer cells, thus, can be used as an adjuvant anti-cancer therapy.Entities:
Keywords: Rosa damascena; anti-cancer activity; bio-elicitors; callus induction; colorectal cancer cell line
Mesh:
Substances:
Year: 2022 PMID: 36234779 PMCID: PMC9572977 DOI: 10.3390/molecules27196241
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
The effect of bio-elicitors on R. damascena callus development and total crude weight.
| Treatments | 1 Fresh Weight | Dry Weight | Crude Weight |
|---|---|---|---|
| Control | 2 2.166 ab | 0.214 b | 0.038 a |
| Citric acid 0.5 g/L | 1.267 b | 0.168 b | 0.022 a |
| L-ascorbic acid 0.5 g/L | 2.878 a | 0.306 a | 0.032 a |
| L.S.D at 5% | 1.019 | 0.075 | 2922.8 |
1 Each treatment was represented by ten replicates, each with three explants. 2 Means with different letters within the same column or row differ significantly (p < 0.05).
Figure 1Callus adequate mass (A); GC–MS chromatograms of callus elicited by control (B); citric acid (C); L–ascorbic acid (D).
GC–MS analysis of R. damascena callus in the control treatment.
| Peak | R. Time | Area | Area % | Name |
|---|---|---|---|---|
| 1 | 5.72 | 2561 | 1.04 | (2,3-Dihydro-5,10,15,20- tetraphenyl [2-(2)H1]prop hyinato) copper(II) |
| 2 | 22.12 | 2251 | 9.15 | Benzonitrile (CAS) |
| 3 | 26.31 | 3938 | 1.60 | 1-Pentanol, 2,2-dimethyl-(CAS) |
| 4 | 34.65 | 3385 | 13.75 | Octadecanoic acid, methyl ester (CAS) |
| 5 | 39.20 | 3807 | 1.55 | 4-Octanol, propanoate |
| 6 | 41.56 | 7511 | 3.05 | 1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester (CAS) |
| 7 | 45.46 | 4280 | 1.74 | 2,6-Nonadien-1-ol |
| 8 | 53.51 | 2360 | 0.96 | (5,10,15,20-Tetraphenyl [2-(2)H1]prophyrinato)zinx(II) |
GC–MS analysis of R. damascena callus in the citric acid treatment.
| Peak | R. Time | Area | Area % | Name |
|---|---|---|---|---|
| 1 | 5.80 | 3614 | 0.95 | Dichloroacetaldehyde |
| 2 | 16.85 | 4391 | 1.16 | Dodecane, 5,8-diethyl-(CAS) |
| 3 | 19.39 | 7554 | 2.00 | Tetradecane (CAS) |
| 4 | 21.82 | 1355 | 3.58 | Tetratetracontane (CAS) |
| 5 | 32.26 | 2202 | 5.82 | Octadecane, 2-methyl- |
| 6 | 41.57 | 1018 | 2.69 | 1,2-Benzenedicarboxylic acid, diisooctyl ester (CAS) |
| 7 | 45.75 | 2866 | 0.76 | 3,3′,5,5′-Tetrabromo-2-nitro-2′-propylsulfonylbiphenyl |
| 8 | 53.28 | 2764 | 0.73 | 5á-Pregnan-20-one, 3à,11á,17,21-tetrakis(trim ethylsiloxy)-, O-methyloxime |
GC–MS analysis of R. damascena callus in the L-ascorbic acid treatment.
| Peak | R. Time | Area | Area % | Name |
|---|---|---|---|---|
| 1 | 7.03 | 2904 | 1.79 | 11-[(t-Butyldimethylsilyl)oxy]-6,9a-dimethyl-6-(m ethoxycarbonyl)-(perhydro )napthaleno[a]benzofulvene |
| 2 | 20.80 | 1980 | 1.22 | Mixture of: 5,6-Dihydro-6-methy l-2H-pyran-2-one and 5-methoxy-3-pente ne-2-ol |
| 3 | 26.34 | 3210 | 1.98 | Nonane, 1-chloro-(CAS) |
| 4 | 30.98 | 9453 | 5.82 | Hexadecanoic acid, methyl ester (CAS) |
| 5 | 34.21 | 1391 | 8.57 | 7-Octadecenoic acid, methyl ester (CAS) |
| 6 | 37.47 | 1777 | 1.09 | (2,3-Dihydro-5,10,15,20-tetraphenyl [2-(2)H1]prophyrinato)copper(II) |
| 7 | 41.55 | 2884 | 17.75 | 1,2-Benzenedicarboxylic acid, mono(2-ethylhexyl) ester |
| 8 | 48.32 | 1799 | 1.11 | 6-[2′-(4″-Phenyl)ethyl]-1,2,3-triphenyl-9H-tribenzo[a,c,e]cycloheptatriene |
Figure 2Cellular cytotoxicity (A–C); clonogenic assay statistical analysis of plating efficiency (PE) of tested groups blotted at the X axis, PE % = the number of colonies formed/number of cells plated) × 100 blotted at the Y axis, the untreated group showed the highest PE while the LAA group showed the least PE, being significantly lower than the CA, control and untreated groups. * Significance at p < 0.05, ** Significance at p < 0.001, **** Significance at p < 0.0001, ns No significant difference. (D) Clonogenic assay images showing cell colonies stained with crystal violet imaged using inverted light microscope X40 (Olympus CKX41SF, Tokyo, Japan) (E–H). Untreated (E); control (A,F); L-ascorbic acid (B,G); citric acid (C,H).
Figure 3Ki-67 flow cytometry proliferation assay. Untreated (A); control (B); L-ascorbic acid (C); citric acid (D). Statistical analysis for the cell proliferation of different groups blotted on X axis and % of proliferation on Y axis, where proliferation of cells in all groups was significantly lower than the untreated group. **** Significance at p < 0.0001, LAA group showed the lowest proliferation compared to the crude callus-treated (control) and CA-treated groups. * Significance at p < 0.05; there was no significant difference between the control and CA groups (ns) (E).
Figure 4Migration assay at 0, 24 and 48 h. Statistical analysis for the % of wound closure of different groups at 24 and 48 h. * Significance at p < 0.05, ** significance at p < 0.001, *** significance at p = 0.0001, **** significance at p < 0.0001.